Adropin (34-76) (human, mouse, rat)

Overview

Adropin (34-76) is a secretory domain of Adropin. Adropin (34-76) can inhibit cAMP level and glucose production in hepatocytes, and has a hypoglycemic effect. Adropin (34-76) plays an antifibrotic role by inhibiting the GLI1 signaling pathway.

Application

Products | Products > Peptides | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Akt | Products > Signaling Pathways > Gli | Products > Signaling Pathways > JNK | Products > Signaling Pathways > PKA

Product Information

• Catalog No.: HY-P4860
• CAS No.: 1802086-30-1
• Molecular Formula: C190H293N55O68S2
• Molecular Weight: 4499.82
• Purity: 98.23%
• Storage: Sealed storage, away from moisture and light. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (0.56 mM); Clear solution
• Availability: In-stock

Source

Original product source